Back

PRIME Education, Inc. (PRIME®)

  • Pulmonary Arterial Hypertension

Maximizing Outcomes in PAH: Targeted Therapies and Evidence-Based Treatment Strategies

Effective management of pulmonary arterial hypertension (PAH) relies on a clear understanding of the key pathogenic pathways and the use of targeted, guideline-directed therapies. Optimizing treatment requires careful selection, combination, and escalation of available therapies to improve outcomes and maintain patient function over time. Tune in this final video podcast of our three-part series as leading experts review the major PAH pathways, discuss currently approved targeted therapies, and highlight evidence-based strategies for implementing guideline-recommended treatment and escalation. Stream the podcast video or the audio-only version and access downloadable clinical resources and point-of-care tools to support pathway-directed therapy, risk-based decision-making, and ongoing management of patients with PAH.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes On-demand / recorded video
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Nov 19, 2025
  • Last day to claim credit
    Nov 19, 2026 6 weeks left